Evaluating the Impact of the HeartHab App on Motivation, Physical Activity, Quality of Life, and Risk Factors of Coronary Artery Disease Patients: Multidisciplinary Crossover Study.


Journal

JMIR mHealth and uHealth
ISSN: 2291-5222
Titre abrégé: JMIR Mhealth Uhealth
Pays: Canada
ID NLM: 101624439

Informations de publication

Date de publication:
04 04 2019
Historique:
received: 25 04 2018
accepted: 10 02 2019
revised: 30 11 2018
entrez: 5 4 2019
pubmed: 5 4 2019
medline: 5 4 2019
Statut: epublish

Résumé

Telerehabilitation approaches have been successful in supporting coronary artery disease (CAD) patients to rehabilitate at home after hospital-based rehabilitation. However, on completing a telerehabilitation program, the effects are not sustained beyond the intervention period because of the lack of lifestyle adaptations. Furthermore, decline in patients' motivation lead to recurrence of disease and increased rehospitalization rates. We developed HeartHab, using persuasive design principles and personalization, to enable sustenance of rehabilitation effects beyond the intervention period. HeartHab promotes patients' understanding, motivates them to reach personalized rehabilitation goals, and helps to maintain positive lifestyle adaptations during telerehabilitation. This study aimed to investigate the impact of the HeartHab app on patients' overall motivation, increasing physical activities, reaching exercise targets, quality of life, and modifiable risk factors in patients with CAD during telerehabilitation. The study also investigated carryover effects to determine the maintenance of effects after the conclusion of the intervention. A total of 32 CAD patients were randomized on a 1:1 ratio to telerehabilitation or usual care. We conducted a 4-month crossover study with a crossover point at 2 months using a mixed-methods approach for evaluation. We collected qualitative data on users' motivation, user experience, and quality of life using questionnaires, semistructured interviews and context-based sentiment analysis. Quantitative data on health parameters, exercise capacity, and risk factors were gathered from blood tests and ergo-spirometry tests. Data procured during the app usage phase were compared against baseline values to assess the impact of the app on parameters such as motivation, physical activity, quality of life, and risk factors. Carryover effects were used to gather insights on the maintenance of effects. The qualitative data showed that 75% (21/28) of patients found the HeartHab app motivating and felt encouraged to achieve their rehabilitation targets. 84% (21/25) of patients either reached or exceeded their prescribed physical activity targets. We found positive significant effects on glycated hemoglobin (P=.01; d=1.03; 95% CI 0.24-1.82) with a mean decrease of 1.5 mg/dL and high-density lipoprotein (HDL) cholesterol (P=.04; d=0.78; 95% CI 0.02-1.55) with a mean increase of 0.61 mg/dL after patients used the HeartHab app. We observed significant carryover effects on weight, HDL cholesterol, and maximal oxygen consumption (VO Persuasive design techniques integrated in HeartHab and tailoring of exercise targets were effective in motivating patients to reach their telerehabilitation targets. This study demonstrated significant effects on glucose and HDL cholesterol and positive carryover effects on weight, HDL cholesterol, and VO ClinicalTrials.gov NCT03102671; https://clinicaltrials.gov/ct2/show/NCT03102671 (Archived by WebCite at http://www.webcitation.org/76gzI9Pvd).

Sections du résumé

BACKGROUND
Telerehabilitation approaches have been successful in supporting coronary artery disease (CAD) patients to rehabilitate at home after hospital-based rehabilitation. However, on completing a telerehabilitation program, the effects are not sustained beyond the intervention period because of the lack of lifestyle adaptations. Furthermore, decline in patients' motivation lead to recurrence of disease and increased rehospitalization rates. We developed HeartHab, using persuasive design principles and personalization, to enable sustenance of rehabilitation effects beyond the intervention period. HeartHab promotes patients' understanding, motivates them to reach personalized rehabilitation goals, and helps to maintain positive lifestyle adaptations during telerehabilitation.
OBJECTIVE
This study aimed to investigate the impact of the HeartHab app on patients' overall motivation, increasing physical activities, reaching exercise targets, quality of life, and modifiable risk factors in patients with CAD during telerehabilitation. The study also investigated carryover effects to determine the maintenance of effects after the conclusion of the intervention.
METHODS
A total of 32 CAD patients were randomized on a 1:1 ratio to telerehabilitation or usual care. We conducted a 4-month crossover study with a crossover point at 2 months using a mixed-methods approach for evaluation. We collected qualitative data on users' motivation, user experience, and quality of life using questionnaires, semistructured interviews and context-based sentiment analysis. Quantitative data on health parameters, exercise capacity, and risk factors were gathered from blood tests and ergo-spirometry tests. Data procured during the app usage phase were compared against baseline values to assess the impact of the app on parameters such as motivation, physical activity, quality of life, and risk factors. Carryover effects were used to gather insights on the maintenance of effects.
RESULTS
The qualitative data showed that 75% (21/28) of patients found the HeartHab app motivating and felt encouraged to achieve their rehabilitation targets. 84% (21/25) of patients either reached or exceeded their prescribed physical activity targets. We found positive significant effects on glycated hemoglobin (P=.01; d=1.03; 95% CI 0.24-1.82) with a mean decrease of 1.5 mg/dL and high-density lipoprotein (HDL) cholesterol (P=.04; d=0.78; 95% CI 0.02-1.55) with a mean increase of 0.61 mg/dL after patients used the HeartHab app. We observed significant carryover effects on weight, HDL cholesterol, and maximal oxygen consumption (VO
CONCLUSIONS
Persuasive design techniques integrated in HeartHab and tailoring of exercise targets were effective in motivating patients to reach their telerehabilitation targets. This study demonstrated significant effects on glucose and HDL cholesterol and positive carryover effects on weight, HDL cholesterol, and VO
TRIAL REGISTRATION
ClinicalTrials.gov NCT03102671; https://clinicaltrials.gov/ct2/show/NCT03102671 (Archived by WebCite at http://www.webcitation.org/76gzI9Pvd).

Identifiants

pubmed: 30946021
pii: v7i4e10874
doi: 10.2196/10874
pmc: PMC6470465
doi:

Banques de données

ClinicalTrials.gov
['NCT03102671']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e10874

Informations de copyright

©Supraja Sankaran, Paul Dendale, Karin Coninx. Originally published in JMIR Mhealth and Uhealth (http://mhealth.jmir.org), 04.04.2019.

Références

Eur J Prev Cardiol. 2017 Jul;24(10):1017-1031
pubmed: 28420250
Clin Rehabil. 2010 Apr;24(4):319-27
pubmed: 20176771
J Med Internet Res. 2017 Jun 29;19(6):e232
pubmed: 28663162
Eur J Prev Cardiol. 2016 Apr;23(6):636-48
pubmed: 25687109
Eur J Cardiovasc Prev Rehabil. 2010 Feb;17(1):1-17
pubmed: 19952757
J Telemed Telecare. 2015 Jan;21(1):45-53
pubmed: 25475219
Int J Cardiol. 2006 Aug 28;111(3):343-51
pubmed: 16316695
Eur J Prev Cardiol. 2016 May;23(7):674-82
pubmed: 26289723
J Cardiopulm Rehabil Prev. 2015 Nov-Dec;35(6):380-9
pubmed: 26034937
J Am Heart Assoc. 2013 Oct 21;2(5):e000418
pubmed: 24145743
Med Sci Sports Exerc. 2000 Sep;32(9 Suppl):S498-504
pubmed: 10993420
J Am Coll Cardiol. 2016 Jan 5;67(1):1-12
pubmed: 26764059
Eur J Prev Cardiol. 2014 Nov;21(2 Suppl):26-31
pubmed: 25354951
Eur J Prev Cardiol. 2016 Dec;23(18):1994-2006
pubmed: 27600690
Eur J Prev Cardiol. 2013 Jun;20(2 Suppl):12-6
pubmed: 23702985
Eur J Prev Cardiol. 2017 Nov;24(16):1708-1717
pubmed: 28925749

Auteurs

Supraja Sankaran (S)

Expertise Center for Digital Media, Hasselt University, Diepenbeek, Belgium.

Paul Dendale (P)

Department of Cardiology, Heart Center, Jessa Hospital, Hasselt, Belgium.
Faculty of Medicine and Life Sciences, Hasselt University, Diepenbeek, Belgium.

Karin Coninx (K)

Expertise Center for Digital Media, Hasselt University, Diepenbeek, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH